A Diverse Team of Experts. A Singular Focus.

With an established history of success launching innovative technologies and years of experience, the Next Science leadership team is dedicated to delivering breakthrough solutions to a global issue. Together, with its research and industry partners, Next Science is developing new and sustainable ways to address the problem of biofilm.

Judith Mitchell

Chief Executive Officer

Judith Mitchell joined Next Science in August 2017. Most recently Ms. Mitchell was President, DePuy Synthes Asia Pacific, the Orthopaedics Division of J&J. Prior to that Ms. Mitchell was the President of Asia Pacific for Synthes GmbH, the world leaders in Orthopaedic trauma care. Before joining Synthes in 2004, Ms. Mitchell held a variety of positions at Cochlear Limited in Product Development, Global Marketing and Education. Ms. Mitchell started her med tech career at GE Medical Systems where over a 14-year career she held positions in sales, marketing, and management.

Dr. Matthew Myntti

Chief Technology Officer

Dr. Matt Myntti is the founder of Next Science and has overall responsibility for all research and development at the company. He leads product ideation, research, and development of all Next Science technologies. Dr. Myntti received his Master’s and Doctoral degrees in Materials Science and Engineering from the University of Dayton and has in excess of 25 granted US patents. Previously at Medtronic Surgical Technologies, he led the biomaterials group which developed novel ENT and neurologic products.

James Mozley

Executive Director, Americas

Jim Mozley is responsible for overseeing a diverse team of talented and creative scientists and engineers to drive research and development of a wide range of innovative technologies for Next Science and its partners. Mr. Mozley received a Bachelor of Science degree from the Georgia Institute of Technology and has over 40 years of management experience with 35 of those years leading successful ventures as CEO.

Byron Darroch

Executive VP, Global

Byron Darroch is an accomplished executive who focuses on successfully steering young organizations through dynamic change and accelerated growth. As a life-long learner, creator, and implementer of innovative, new business models and strategies, Byron is dedicated to disrupting old industry paradigms. Previously, as General Manager and Head of Business Development at Atomo Diagnostics, a fast-growing diagnostics company supported by the Gates Foundation, Byron helped bring large-scale HIV self-testing to the global market. Byron is leading the Partnerships team for Next Science.

Daniel Canon

VP, Operations

Previously, as a Senior Engineering Manager at Medtronic, Dan was involved in managing new company acquisitions, developing, and executing subsequent business integration strategies, assuring medical device production quality. Mr. Canon has been leading complex projects in military, commercial, defense, and medical operational and manufacturing environments for over 20 years. He holds a Bachelor's Degree in Electrical Engineering from Pennsylvania State University and a Master’s Degree in Mechanical Engineering from the University of Maryland.

Don Ayers

VP, Market Access

As VP of Market Access for Next Science, Don is responsible for coordinating and supporting all sales and market development initiatives in wound care. Mr. Ayers brings 25 years of healthcare experience to Next Science with a focus on the introduction and commercialization of advanced and innovated products into the marketplace. Previously he has held sales and national accounts director positions with fast-paced growth companies such as MiMedx, Shire, Advanced BioHealing, and Smith & Nephew.

In the News

Learn about the latest news and events from Next Science and its partners.